In 2012 the US FDA suggested the use of mathematical models to assess the impact of releasing new nicotine or tobacco products on population health outcomes. A model based on system dynamics methodology was developed to project the potential effects of a new nicotine product at a population level. A model representing traditional smoking populations (never, current and former smokers) and calibrated using historical data was extended to a two-product model by including electronic cigarettes use statuses. Smoking mechanisms, such as product initiation, switching, transition to dual use, and cessation, were represented as flows between smoking statuses (stocks) and the potential effect of smoking renormalisation through a feedback system. Mortality over a 50-year period (2000e2050) was the health outcome of interest, and was compared between two scenarios, with and without e-cigarettes being introduced. The results suggest that by 2050, smoking prevalence in adults was 12.4% in the core model and 9.7% (including dual users) in the counterfactual. Smoking-related mortality was 8.4% and 8.1%, respectively. The results suggested an overall beneficial effect from launching e-cigarettes and that system dynamics could be a useful approach to assess the potential population health effects of nicotine products when epidemiological data are not available.
Introduction
Smoking-related mortality affects approximately 6 million people per year worldwide (World Health Organization, 2016a) . Despite public health campaigns and tobacco control policies, tobacco use remains a major public health concern in Europe (Organisation for Economic Co-operation and Development, 2014) , as well as in emerging countries (World Health Organization, 2016b) . Policy makers and regulators have considered new nicotine products as potential alternatives to complement cessation within their tobacco harm reduction strategies. The US Food and Drug Administration released guidance for 'modified-risk tobacco products' (MRTPs) in 2012, describing the requirements for products that wish to claim reduced harm (Food and Drug Administration, 2012) . Being granted permission to claim a reduced risk with respect to conventional cigarettes could become a valuable marketing tool attracting an important segment of current smokers. New nicotine products that potentially offer reduced exposure to toxicants, reduced toxicity and a reduced health risk to consumers compared with conventional cigarettes, are being developed and introduced in markets worldwide. These next generation products (NGPs), include tobacco heated products, smokeless tobacco and other nicotine products, such as ecigarettes.
The tobacco industry is developing methodologies to characterise nicotine products within a risk spectrum (Lowe et al., 2015) . However, factors beyond nicotine product chemistry and its direct biological effect are likely to have an impact on the potential risk/ benefit of launching a product in terms of population health effects. For example, if the introduction of a new product with lower health risks than smoking but with risk higher than complete nicotine cessation leads to prolongation of exposure to harmful constituents, especially if used in conjunction with traditional tobacco products, as the smoker may have quit smoking altogether had the new product not been available then, the overall effect could be harmful even when the intrinsic risk of the product is lower than cigarettes. Literature has also pointed to the possibility that some of these products could be attractive to non-tobacco users (De Andrade et al., 2013) and used as gateway products leading to more harmful products, especially those aged <20 years. Another potential scenario that authorities have expressed concern is over the possibility that even if new nicotine product users do not progress to cigarettes, the use of the new products could re-normalise the social perception of smoking (Fairchild et al., 2014) , and reverse the recent decline in smoking prevalence. In this context, mathematical models can be valuable tools for assessing different scenarios by providing simplified representations of these behaviours and mechanisms. Then different parameters and assumptions are introduced in comparative scenarios to help identify tipping points between benefit and burden for a set of parameters of interest.
Simulation models have an established and effective record when studying the potential health impacts of smoking. Models have been used to assess the impact of regulatory policies (Levy et al., 2006) , such as a simulation model to assess the ban on menthol cigarettes (Levy et al., 2011) , and to assess investment in smoking cessation services (Tobias et al., 2010) . More recently, in response to changes in the nicotine product landscape, simulation models for product assessment have been suggested using different methodologies (Bachand and Sulsky, 2013; Vugrin et al., 2015; Weitkunat et al., 2015) .
In this study, we built on previous system models used by regulators for policy assessment to describe a compartmental model developed using system dynamics and aimed to investigate the potential health effects of launching an NGP, while maintaining model simplicity and transparency. This multiproduct model incorporated feedback mechanisms to assess the potential renormalisation of smoking as a result of launching a new product. We illustrate our approach with the introduction of e-cigarettes in the UK as e-cigarettes are still a relatively novel product but for which some information is available. In this case-study, we assessed the effect on mortality and smoking prevalence of launching e-cigarettes in the UK and what could be the effect of a potential renormalisation of smoking. Although there are a wide range of e-cigarettes in the UK market with potentially different toxicant emissions, for this case study, we are considering them as a category with a nominal intrinsic risk. This simplification will facilitate the study of the effect of using different estimates for the intrinsic risk of e-cigarette use on all-cause mortality.
Methods
We used a system dynamics approach to model the potential health impacts of an NGP in the tobacco market place. The quantified system dynamics model was constructed using Vensim ® DSS version 6.3c (Ventana Systems Inc., MA, USA) and the packaged interfaced version Sable Developer v5.1.492 (Ventana Systems UK Ltd, UK) was used to visualise results. Model development was conducted over two phases. In phase one, the Core Model was defined to represent the structure of traditional smoking populations (never smoker, current smoker and former smoker) and calibrated with historical data. During phase two, the Core Model was extended to a two product model (the NGP Conceptual Model), in which both cigarettes and a single NGP exist, and included subpopulations of current and former NGP users.
System dynamics models describing tobacco-use behaviour mechanisms represent a population as a system, with separate groups of people with similar smoking behaviour characteristics (stocks). As a stock is required for each population group with similar characteristics, system dynamics models can become structurally complex, limiting their ability to represent demographically diverse population groups. We required the model to represent population groups characterised by smoking status categorised by gender and age cohorts within a single stock, as transition rates between smoking status and relative risk (RR) for allcause mortality are influenced by these parameters. The model also considers time since quitting as this parameter is directly linked to relative risks after smoking cessation and product switching. We strived to maintain the overall transparency of the model structure and flexibility, whilst modelling at a greater level of complexity, to provide an appropriate representation of smoking behaviours and mechanisms. Age cohorts rather than individual ages were used due to a lack of available data to inform the model at the single year age cohort level.
Core model
The Core Model used individual stocks to represent the traditional smoking populations of 'never smoker', 'current smoker' and 'former smoker' (Fig. 1) . Never smokers were defined as individuals having smoked <100 cigarettes in their lifetime; current smokers, as those having smoked >100 cigarettes in their lifetime and still smoking, this definition of smokers includes hand-rolled cigarette smokers but excludes smokers of any other tobacco product such as pipes and cigars; and former smokers, as individuals that used to smoke but that no longer smoke.
An overview of the Core Model is shown in Fig. 1 with stocks representing smoking status and flows the transition rates between these stocks. The model used birth and migration rates (net migration) to present a more realistic portrait of the population. All-cause mortality was measured by applying mortality rates to stocks based on smoking status, age, gender and time since quitting smoking. In the diagram, inflows correspond to the projected population birth rate going into the stock of never smokers and migration flows into each stock proportional to the number of people in each stock. Migrant smoking status was assumed to be proportional to UK stocks because we did not have information regarding their smoking status. Model outflows were determined by the mortality rates associated with each stock. Flows within the model represent classic smoking behaviour, people remaining as a never smoker unless they initiated cigarette smoking. Those that initiated smoking transitioned to the stock of current smokers, where they remained until they quit (or die). Those that quit smoking transferred to the stock of former smokers that had been abstinent from smoking for <1 year. Former smokers were subdivided into separate stocks based on the period of abstinence, gender and age cohorts. As the period of abstinence increased, the former smoker transferred through stocks of quit periods. At each abstinence period, smokers could relapse back to smoking with different relapse rates. Additionally, within each stock, an automated mechanism was employed to simulate aging along age Where t ¼ current time.
Other parameters calculated were RRs for different smoking statuses with respect to never smokers. RRs were defined for different stocks as the ratio of the likelihood of dying with respect to never smokers. The RR estimates for former smokers were dependent on the time since quitting (Qt). We used a negative exponential distribution, which was shown to fit well to the incidence of diseases, such as chronic obstructive pulmonary disease and stroke (Lee et al., 2014a (Lee et al., , 2014b ) after quitting smoking: (2); H ¼ all-cause smoking-related mortality risk halflife after quitting smoking.
Estimated population deaths by age and gender in 2000 were imported into the Core Model and used to generate mortality rates for never smokers, by gender and age using:
Where mx ¼ annual mortality probability; G ¼ gender; A ¼ age; NS ¼ never smoker; CS ¼ current smoker; FS ¼ former smoker.
Mortality rates were calculated using:
Relative Risk GA ðQtÞ
From all-cause mortality we also derived smoking attributed mortality (SAM) via the population-attributable fraction (PAF). Our approach to calculating PAF was the most commonly used (Wacholder et al., 1994) and was calculated as:
Where n¼3, total number of population smoking groups; i¼ith population smoking group; p i ¼ prevalence of exposure in the population smoking group; RR i ¼ relative risk for disease associated with the population smoking group.
Then SAM can be written as:
. Smoking normality effect
The normality of smoking is believed to be a leading risk factor for smoking initiation (Hudson and Thomson, 2011) , and to have an influence on smokers attempting to quit (Pearson et al., 2014) . To address the concerns that NGP use may renormalize cigarette smoking, the Core Model incorporated an estimate of smoking normality, and an estimate of the effect it had on smoking initiation and quit rates (Fig. 2) .
The model used adult smoking prevalence as a proxy measurement of visual exposure to smokers and via calibration with published data on smoking prevalence by age and gender for 2000e2013, quantified the elasticity of changes in visual exposure to changes in initiation and quitting rates. The normality effect is mathematically expressed as:
Normality Effect on Initiation 
Core model data inputs
Different categories defining the stocks were chosen to closely reflect the main sources of public data and minimise data manipulation. Age categories were chosen in agreement with smoking prevalence sources (Office for National Statistics, 2013a). Annual smoking relapse probabilities for former smokers were parameter inputs to the model, based on the time since quitting (Hawkins et al., 2010 ; Office for National Statistics, 2009). The initial distribution of former smokers by time since quitting was constructed from smoking-related behaviour and attitudes surveys (Office for National Statistics, 2009).
Core Model data sources are shown in Table 1 . All-cause mortality RRs between smokers and never smokers were not available from institutional sources. Therefore, a metaanalysis of 49 published UK studies was conducted to estimate the risk of total mortality in relation to conventional cigarette smoking. Due to a lack of UK studies considering age at death, ageindependent RR estimates for male and female current smokers were identified with 95% confidence intervals (CI) for use within the Core Model. This meta-analysis generated gender specific allcause mortality RRs of 1.81 and 1.66 for males and females over the age of 35, respectively, with former-smoker mortality half-life
estimated to be 9 years (study commissioned to P N Lee Statistics and Computing Ltd, data not shown). However, no age-specific or smoking consumption-related RRs could be estimated. Mortality rates for England & Wales for never smokers were extracted from the UK Office for National Statistics (ONS) and extrapolated to the whole of the UK (Office for National Statistics, 2014b).
The Core Model used projected birth rates from the ONS. Net migration was broken down by gender and age. As few data were available on smoking prevalence of net migration, the same smoking population distributions were assumed as estimated by never smoker current smoker former smoker initiation rate quit rate base quit probability base initiation probability uk population adult smoking prevalence normality of smoking initiation elasticity to smoking normality quit elasticity to smoking normality Fig. 2 . Smoking normality feedback loop. The diagram shows that an increase in the number of smokers increases the adult smoking prevalence; as more people smoke then smoking is likely to become more acceptable (normality effect) leading to an increase in the number of current smokers which closes the loop. The other direction is also possible linking lower smoking prevalence with higher quitting rates. A review of the literature found no reliable estimates of UK smoking initiation rates. Therefore, smoking initiation rate estimates were based on data of the age at which regular smokers, both current and ever, started to smoke and a study of smoking prevalence in young people, which monitored smoking, drinking and drug use among secondary school pupils aged 11e15 years (Office for National Statistics, 2013a; Health & Social Care Information Centre, 2013). The Core Model assumed no initiation by children aged <11 years. This method provided a base probability of smoking initiation by age and gender for the initial year of the simulation. In subsequent years, the initiation probability was adjusted for an estimated impact that the normality of smoking within the population had upon smoking initiation rates.
For smoking cessation, a review of the literature revealed estimates of the probability of quitting, which were aggregated across age cohorts. Using the aggregated values as a baseline estimate, age cohort adjustments were applied via model calibration to ONS estimated prevalence by age and gender for the period 2000e2013 (Appendix A).
Other parameters estimated through calibration were the elasticity of smoking initiation rate and quit rate to changes in smoking normality, estimated at 0.5 and À0.108, respectively.
The following assumptions were introduced due to lack of reliable data: relapse rates were not gender or age specific and nicotine usage distribution for net migration was assumed to follow the same distribution as for the UK. Public data sources considered that RRs for age <35 years were the same across nicotine use statuses and nicotine usage initiation rates were applied from age 11 years and for age <11 years were considered to be zero.
All Core Model data input values are shown in Appendix A.
NGP conceptual model
The Core Model was expanded to a two product model, in which both cigarettes and a single NGP, in this case e-cigarette, coexist. NGP launch is likely to change behaviours of existing smokers, as well as the potential for NGP initiation by never and former smokers. To illustrate the model capabilities, population and smoking prevalence data for the UK was used, along with data assumptions for e-cigarettes as the NGP. The model was initialised with UK data estimates for the year 2000 and the simulated period was from 2000 to 2050 with a time interval of one-quarter of a year. The NGP Conceptual Model is shown in Fig. 3 .
The NGP Conceptual Model divided the UK population into nine stocks with homogenous smoking characteristics. Transition behaviour was determined by current smoking status and was independent of previous smoking history. The matrix of viable transitions used by the model is shown in Table 2 .
The excess health risk of NGP use was based on an estimated RR for that of smoking cigarettes (Weitkunat et al., 2015) . 
NGP User Excess
Where the Risk Ratio is the expected potential risk of the NGP with respect to smoking (in our baseline scenario 0.05) and, Qt(CS) is the time since quit smoking and Qt(NGP) the time since quit NGP. Note that the model did not adjust for reductions in risk due to potentially lower cigarette consumption rates for dual users.
NGP Conceptual Model data sources. Expansion of the Core Model to the NGP Conceptual Model increased the data input requirements to characterise the NGP. As an NGP is unlikely to have any in-market data available, many of the pre-market estimates of inputs were set as scaled values of the equivalent cigarette values from the Core Model. For switching between products, estimated annual probabilities were used with data sources displayed in Table 3 .
When former NGP users relapse, the model default was to return to the last product used. However, constant proportions were allocated to allow relapse to a different product than the one previously used. Two supplementary inputs were included to represent conditional behaviours. These included the proportion of NGP use by never smokers that would have initiated cigarettes had the NGP not existed, and the proportion of smokers that switched to the NGP that would have quit smoking in the next 12 months had the NGP not existed. These conditional parameters allowed assessment of the potential burden of these aspects and comparison against the overall population effect. Tables indicating the extended model input parameters are included in Appendix B.
Two additional assumptions were introduced into the NGP Conceptual Model: people relapsing to smoking had the same RRs as any other smokers of that age category (i.e. there is no benefit in quitting smoking for short periods of time); and dual users had the same RRs as current smokers. There is no scientific agreement regarding the potential for harm reduction from e-cigarette dual use. We took a conservative approach and assumed dual use to have the same RR as current smokers.
Modelling of scenarios
Two projected scenarios were simulated for the period 2000e2050: 1. A status quo scenario where the NGP product did not exist; and 2. A counterfactual scenario in which the NGP (e- Input parameter Counterfactual scenario model assumptions E-cigarette awareness E-cigarettes were introduced in 2006, initially with low public awareness and uptake. All current smokers were aware by 2020 and never smokers were aware by 2025. E-cigarette harm
We assumed e-cigarettes were 5% as harmful as traditional cigarettes (West and Fidler, 2010 ). E-cigarette contribution to smoking normality
We assumed e-cigarette users had a lower (50%) contribution to smoking normality than a current smoker. Changes in smoking normality had 50% of the impact on e-cigarette initiation rates as they had on cigarette initiation. E-cigarette initiation E-cigarette initiation was proportional to cigarette initiation rates, scaled at a ratio of 0.1. Among never smokers that took up e-cigarettes, it was assumed that 75% would have smoked cigarettes if they had not initiated ecigarette use. E-cigarette quit probability E-cigarette users had the same quit probability as smokers. Product switching Among e-cigarette users that did not quit, we assumed that 5% per year switched to cigarettes and 5% became dual users. We assumed that 5% of current smokers switched annually to e-cigarettes and another 10% switched to dual use. Among current smokers that switched products, it was assumed that 50% would have quit cigarettes had they not switched.
Relapses
All relapse probabilities were assumed to be the same as that for a Former Cigarette Smoker relapse probabilities, based on period of abstinence. 
Status quo scenario
The status quo, where e-cigarettes did not exist, used the calibrated model inputs of the Core Model and used them to project to 2050.
Counterfactual scenario
With only limited scientific data available for e-cigarettes, counterfactual use is hypothetical until data becomes available. The counterfactual scenario used the same input parameter values as the status quo scenario, with the additional inputs described in Table 4 .
Results

Core model calibration and validation
Model verification tests were used to validate the model. All model equations passed dimensional consistency checks, a mass balance check for population leakage, sensitivity testing to key input parameters, and test cases of extreme input values. The appropriateness of the model structure was also subject to several workshop reviews by subject matter experts.
The Core Model was calibrated using historical data (2000e2013) from the ONS and UK population projections for the period 2010e2050 were compared against those forecast by the ONS (Office for National Statistics, 2013b) (Fig. 4) . The timeline for projections was set to 2050 to allow enough time for health impacts to start being realised. Long-term projections were required given that former smoker mortality half-life (time that takes the excess risk of a former smoker to be half of current smokers) was provided as 9 years. Fig. 5 shows the projected adult smoking prevalence to 2050 by the Core Model, which estimated smoking prevalence at 12.4% (among adults þ16). No other long-range projection models for the UK have been reported, but smoking prevalence estimates for the United States have been projected at 12.5% and 8% for 2050 (Verzi et al., 2012; Vugrin et al., 2015) . estimated to be 78,550,000 in the status quo scenario and an increase of 10,000 people in the counterfactual scenario, reaching 78,560,000. By 2050, cigarette smoking prevalence was projected to fall to 10.5 (12.4% in adults 16þ), with respect to the overall population, in the status quo scenario while the counterfactual scenario projection was 8.2% (9.7% in adults) including dual users. The percentage of the population that have never smoked was 69.5% in the status quo scenario and in the counterfactual scenario was projected to increase slightly to 69.9% and, also the number of former smokers was projected to rise to 21.5% in the counterfactual scenario compared to 20.0% in the status quo scenario (Fig. 6 ).
Smoking prevalence and former smoking prevalence projections over the period 2000e2050 for each scenario are shown in Fig. 7 . The use of e-cigarettes was projected to peak around 2020, at approximately 10% of the UK population (Fig. 8A ) and by 2032, nearly 39% of current smokers were expected to also be using ecigarettes (Fig. 8B) . The number of former smokers projected to switch to e-cigarettes peaked around 2032, at just fewer than 32%. The use of e-cigarettes by never smokers never exceeded 0.5% of the population in our simulation (Fig. 8B ).
Smoking-related mortality
The proportion of all deaths due to smoking-related diseases in 2050 was projected to fall to 8.4% in the status quo scenario compared to 8.1% in the counterfactual scenario. For those aged <75 years, it was projected to fall to 11.2% in the status quo scenario and 10.5% in the counterfactual scenario (Fig. 9) .
Potential harm
We assessed the effect on potential harm of simultaneously changing three parameters: 1. increasing the RR of e-cigarettes; 2. increasing the initiation rate values; and 3. increasing the normalisation effect. A 100% normalization effect means that an ecigarette user has the same normalization effect as a cigarette smoker over smoking prevalence changes while in 50%, two ecigarettes user are equivalent to one smoker. The results of these analyses are shown in Table 5 .
Discussion
Initial expectations anticipated a greater reduction within the counterfactual scenario in smoking-related mortality than forecast, where the relative harm of e-cigarettes was set at 5% of that of conventional cigarettes. However, the model showed that most ecigarette users were current or former smokers. Our simulation assumed no lowering of risk for dual users as explicit cigarette consumption levels were not modelled. Another conservative assumption that may have prevented finding larger differences in mortality between scenarios is the introduction of a first order mechanism implying that any potential health benefit from quitting is lost when relapsing to smoking. The need to introduce assumptions from e-cigarette flows highlights the scarcity of consistent data to enable appropriate data inputs to be used in the model. Data requirements for this type of modelling would benefit from the inclusion and public release of relevant measurements on nicotine products in nationwide studies.
A former smoker's excess risk was modelled with a half-life of 9 years. For smokers that switched to e-cigarettes, the residual excess mortality risk from previous smoking was greater than the excess mortality risk from e-cigarettes for a substantial period. Based on the RRs used in this model for current smokers (male 1.81; female 1.66); it would take over 30 years for the residual excess mortality risk from smoking to be less than the excess risk from using ecigarettes. The availability of e-cigarettes pointed to acceleration of a decline in smoking prevalence compared to the status quo scenario. Smokers quit earlier and although many still relapsed, prevalence of former smokers significantly increased in the counterfactual scenario.
The reduction in smoking prevalence is the result of the combined effects of fewer people initiating smoking and a higher rate of quitting. At the start of both scenarios, around 260,000 people per year started smoking for the first time. In the status quo scenario this fell to 230,000 people per year by 2050 and an even greater decline to 193,000 people per year was seen in the counterfactual scenario. Cumulatively over the 2000e2050 period, over 1 million fewer people initiated smoking in the counterfactual scenario. The lower uptake of smoking was driven by the effect of smoking normality. In the status quo scenario we aligned smoking normality to smoking prevalence within the UK. In the counterfactual scenario the same mechanism was applied, but a single e-cigarette user was equivalent to one-half of a cigarette smoker. The decline in smoking normality also increased the probability of current smokers quitting for >1 year. By 2025, the smoker quit probability rose by 1.2% and by 2050 the probability was 2.4% higher than that seen in the status quo scenario. Overall, the model estimated that under the hypothetical counterfactual scenario, e-cigarettes could potentially reduce the rate of smoking-related mortality.
A model is only as good as the data upon which it relies and due to the relatively recent introduction of e-cigarettes into the UK market, little reliable data is yet available on population behaviour in relation to e-cigarette use. However, we believe that the model developed is a useful tool to integrate data from future scientific reports and surveys regarding alternative products to cigarettes. Output from this model would provide an additional decision aid to product developers and regulators for assessing the potential impact of these products on population health. The effects of changes to marketing restrictions and labelling can be analysed by changing the corresponding initiation and transition probabilities as well as the effectiveness of the product as an aid to quitting smoking.
By inclusion of the feedback effect of smoking normality on initiation and cessation rates, we added an improved dynamic relationship compared with using static probabilities over the 50 year period. This structure could be used to assess claims of the renormalisation of smoking effect that products such as e-cigarettes may have and the dangers that they bring in terms of their overall impact on population health.
Model limitations
The current model only simulates two products, cigarettes and one alternative product. However, in future markets there are likely to be more alternatives to cigarette smoking, such as tobacco heated products and snus. At present, the model characterises the UK population by age and gender only, but studies have shown ethnicity (Karlsen et al., 2012) , social economic status (Hiscock et al., 2012), and education level (Zhu et al., 1996) to be important factors influencing smoking prevalence. The model assessed the impact on population health in the UK in terms of overall mortality rates and smoking-related mortality. We were required to make certain assumptions when constructing the model, for example the lack of available information on smoking prevalence within net migration required the assumption that prevalence was the same as within the UK. Additionally, average consumption rates were assumed throughout the model, but it could be argued that dual users are likely to consume lower numbers of cigarettes than they would if they did not also use e-cigarettes. Relative risks were not linked to duration of smoking so it assumes similar smoking durations within age categories. The Core Model, like all simulation models, is a simplification of reality. At present, the Core Model does not include representations of affordability, smoking bans in public places, health campaigns or packaging regulations, some or all of which may account for the discrepancies seen between the calibrated model and ONS prevalence estimates. However, the purpose of our Core Model was to create a baseline for a scenario where NGPs do not exist, for comparison against a scenario in which they do exist. We deemed the model fit for this purpose as historic and projected smoking prevalence is aligned with external estimates from surveys and other studies and therefore able to provide informative projections to aid pre-market product assessment from the population health perspective.
Conclusions
The results from this study suggested that system dynamics could be a useful approach to assess the potential population health effects of nicotine products when epidemiological data are not available. Using historical data and introducing different assumptions, system dynamics provided a range of scenarios to enable the assessment of the potential effects on mortality from introducing ecigarettes in the UK. The model pointed to beneficial effects from the introduction of e-cigarettes when the status quo scenario was compared to the baseline counterfactual scenario. Most of the results from the sensitivity assessment also suggested of decreasing trends in smoking related mortality by 2050 to be strengthened as result of the introduction of e-cigarettes in the UK.
